While the former Biden administration showcased the Inflation Reduction Act as a key victory in the fight over high drug ...

House Democrats want to know what the Trump administration plans to do after it rescinded a Biden-era executive order to ...

Since taking office for his second term on Jan. 20, 2025, President Donald Trump has issued a series of executive orders (EOs) aimed at ...

Biden-era policies rescinded by Donald Trump could signal a significant shake-up in Medicare and Medicaid drug price reforms.

The second round of Medicare Part D price negotiations will feature two drugs familiar to rheumatologists — Ofev and Otezla — ...

Its weight-loss drug policy would fall to Trump's pick for health secretary, Robert F Kennedy Jr, and Mehmet Oz, Trump's choice to lead Medicare and Medicaid services. But this could mean a potential ...

Early moves by the president raise questions about what direction his second-term policy on drug costs will take.

“Rescinding the cap on insulin at $35 only makes pharmaceutical richer and everyday Americans, including MAGA voters, ...

A provision about insulin in the Inflation Reduction Act is conflated with a 2022 executive order by former President Joe ...

Donald Trump’ s return to the White House— along with a GOP- controlled Senate and House of Representatives— is expected to change that. Republicans in Washington say they plan to use funding cuts and ...

President Trump is rolling back Biden healthcare policies, such as expansions to the Affordable Care Act – a move Democrats ...

At J.P. Morgan, most biopharma executives expressed a neutral stance on the incoming administration, but just days later, ...